Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Price:
35.68 USD
-2.73%
Market Closed
Updated:
Jun 1, 2024
Rhythm Pharmaceuticals Inc
Other Long-Term Assets
|
Rhythm Pharmaceuticals Inc
Other Long-Term Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
Other Long-Term Assets
$14.3m
|
CAGR 3-Years
262%
|
CAGR 5-Years
104%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Long-Term Assets
$9.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
51%
|
CAGR 10-Years
27%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Long-Term Assets
$4.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
25%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Long-Term Assets
$9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
39%
|
CAGR 10-Years
19%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Long-Term Assets
$2.8B
|
CAGR 3-Years
49%
|
CAGR 5-Years
13%
|
CAGR 10-Years
75%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Long-Term Assets
$3.2B
|
CAGR 3-Years
55%
|
CAGR 5-Years
27%
|
CAGR 10-Years
29%
|
See Also
What is Rhythm Pharmaceuticals Inc's Other Long-Term Assets?
Other Long-Term Assets
14.3m
USD
14.3m
USD
Based on the financial report for Mar 31, 2024, Rhythm Pharmaceuticals Inc's Other Long-Term Assets amounts to 14.3m USD.
What is Rhythm Pharmaceuticals Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
104%
104%
Over the last year, the Other Long-Term Assets growth was -17%. The average annual Other Long-Term Assets growth rates for Rhythm Pharmaceuticals Inc have been 262% over the past three years , 104% over the past five years .
You don't have any saved screeners yet
